Hongmei Zhao

机构：Shanghai Eye Disease Prevention & Treatment Center, Eye & ENT Hospital of Fudan University · ORCID：0000-0002-2701-159X

发表论文 68 篇 · 总被引 1432 次 · h-index 19

代表论文

• Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism (2024 · Acta Pharmaceutica Sinica B · 被引 40)
• Single-cell spatial transcriptomics of tertiary lymphoid organ-like structures in human atherosclerotic plaques (2025 · Nature Cardiovascular Research · 被引 25)
• Urate-Lowering Therapy Inhibits Thoracic Aortic Aneurysm and Dissection Formation in Mice (2023 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 23)
• Advances in metabolomics of chronic obstructive pulmonary disease (2023 · Chinese Medical Journal - Pulmonary and Critical Care Medicine · 被引 20)
• Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension (2024 · Acta Pharmaceutica Sinica B · 被引 18)
• Oleanolic acid attenuates obesity through modulating the lipid metabolism in high‐fat diet‐fed mice (2024 · Food Science & Nutrition · 被引 13)